Great analytical view. One needs to weigh risk/reward based on there own research and financial position. In my experience the more negative I hear towards something I hold conviction, the more it drives me to delve deeper. Speaking of MNS only with the negative opinions/falsities taking hold of this forum many moons ago, the more I dug, the more positive I actually found for a counter agrument. I tried patiently to have this constructive dialogue with these individuals to only hear the same ryhthmic rhetroic you hear day in day out with unsubstantiated comments and years later. The fact they are still now posting illiterate comments they were those many moons ago clearly shows their lack of understanding, or more so shows just how hurt they are towards MNS.
To sum up, I would agree with @nagrajuna comments of the downies and your view of risk analysis and we are all big kids now and can make our own decisions based on our risk/reward. GLAH
- Forums
- ASX - By Stock
- MNS
- Magnis chairman
Magnis chairman, page-1620
-
- There are more pages in this discussion • 277 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MNS (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.37M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
MNS (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online